Background illustration for clinical trials search

Paid Clinical Trials Cranston

Discover 492 paid clinical trials in Cranston, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 492

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for

Relapsed/Refractory Primary Central Nervous System Lymphoma

Location: Providence RI, Boston MA, New Haven CT, New York NY,

Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase 3, Recruiting

Personalized Addiction Treatment enHancement

for

Opioid Use Disorder, mHealth, Peer Support

Location: Providence RI

Sponsor: Rhode Island Hospital

Sex: All

Age: 22+

Code: NCT07778394

Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for

Anatomic Stage I Breast Cancer AJCC v8,

Location: Providence RI, Westerly RI, Waterford CT,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase 3, Recruiting

Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome

for

Restless Leg Disorder, Restless Leg Syndrome (RLS), Pregnancy,

Location: Providence RI

Sponsor: Rhode Island Hospital

Sex: Female

Age: 18+

Code: NCT07144631

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for

Rhabdomyosarcoma

Location: Providence RI, Worcester MA, Boston MA, Hartford CT,

Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Emergency Medicine Peer Outreach Worker Engagement for Recovery

for

Substance Use Disorders, Overdose, Opioid Use Disorder,

Location: Providence RI

Sponsor: University of California, Los Angeles

Sex: All

Age: 18+

Code: NCT06320015

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for

Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,

Location: Providence RI, Boston MA, Hartford CT, New Haven CT,

Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia

Location: Providence RI, Boston MA, South Portland ME,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,

Location: Providence RI, Waterford CT, Glastonbury CT,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase 3, Recruiting

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

for

Coronary Arterial Disease (CAD),

Location: Providence RI, Boston MA, Roslyn NY, The Bronx NY,

Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT06959524

Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for

Core Binding Factor Acute Myeloid Leukemia

Location: Providence RI, Boston MA, The Bronx NY, Wilkes-Barre PA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase 2, Recruiting

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

for

Pulmonary Hypertension

Location: Providence RI, Philadelphia PA

Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT07132788

Recruiting

Opioid Management for Discharged Emergency Department Patients

for

Bone Fractures

Location: Providence RI

Sponsor: Addinex Technologies, Inc.

Sex: All

Age: 6+

Code: NCT06592378

Recruiting

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

for

Acute Ischemic Stroke

Location: Providence RI, Morgantown WV, Chicago IL, St Louis MO,

Sponsor: Amrou Sarraj

Sex: All

Age: 18 - 70+

Code: NCT07115940

Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for

Prostate Cancer (Adenocarcinoma)

Location: Providence RI, West Haven CT, Lebanon NH, The Bronx NY,

Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase 3, Recruiting

A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children

for

Sleep, Sleep Quality, Intervention Study, Ethnic Minority

Location: Providence RI

Sponsor: Rhode Island Hospital

Sex: All

Age: 11 - 13

Code: NCT06942455

Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia

Location: Providence RI, Hartford CT, Stony Brook NY, Albany NY,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for

B Acute Lymphoblastic Leukemia

Location: Providence RI, Worcester MA, Boston MA, Hartford CT,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

Platform of Randomized Adaptive Clinical Trials in Critical Illness

for

Respiratory Insufficiency,

Location: Providence RI, New York NY, Philadelphia PA, Sherbrooke,

Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05440851

Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

for

Atrial Fibrillation

Location: Providence RI, Boston MA, Burlington MA, Stony Brook NY,

Sponsor: Johns Hopkins University

Sex: All

Age: 22 - 70+

Code: NCT05836987

Phase 3, Recruiting

Paid Clinical Trials Cranston

Filter results

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

Personalized Addiction Treatment enHancement

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Interested in new trials?

Emergency Medicine Peer Outreach Worker Engagement for Recovery

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

Opioid Management for Discharged Emergency Department Patients

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Platform of Randomized Adaptive Clinical Trials in Critical Illness

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation